Latest news with #CollègedesmédecinsduQuébec
Indianapolis Star
6 days ago
- Health
- Indianapolis Star
Clinique Laflamme Wins the 2025 Consumer Choice Award
MONTRÉAL, QC / ACCESS Newswire The Consumer Choice Award (CCA) is proud to name Clinique Laflamme as the top medical aesthetic clinic in the Greater Montreal area. This prestigious recognition highlights the excellence of an establishment at the intersection of science, cutting-edge technology, and the art of personalized beauty. Since its founding in 2010, Clinique Laflamme has established itself as a leading authority in medical aesthetics in Quebec. Its mission is clear: to place medicine at the service of natural, lasting beauty, while respecting overall well-being, through a personalized approach and the integration of next-generation technologies. At the heart of this vision is Dr. Nathalie Laflamme, a physician recognized in aesthetic medicine by the Collège des médecins du Québec. Certified by the European College of Aesthetic Medicine & Surgery (ECAMS), she is a leading expert in advanced aesthetic injectables and tissue biostimulation, offering holistic and harmonious rejuvenation with natural results and customized care. Creator of the exclusive Lift Laflamme© protocol, she embodies a new generation of aesthetic physicians combining technical mastery with artistic vision. Driven by a constant desire to refine her practice, Dr. Laflamme has expanded her expertise through advanced training in Europe, the United States, and Canada. This ongoing commitment to education allows her to remain at the forefront of the most effective, innovative, and safest medical advancements in the field. Clinique Laflamme offers a full range of high-end medical-aesthetic treatments, including: Next generation injectables: neuromodulators and tailored fillers to smooth wrinkles, sculpt volume, and enhance features with finesse. Laser and light-based technologies: for pigmentation correction, skin tightening, collagen stimulation, and precision hair removal. Non-invasive body contouring: advanced technology solutions designed to sculpt the body without surgery or downtime. Medical-grade skincare: personalized treatments that promote luminous, even, and resilient skin. Tissue biostimulation: a revolutionary breakthrough that reactivates the skin's natural regenerative power, from face to body, for a tightening effect and deep revitalization – all without invasive procedures. 'This award reflects our commitment to delivering ethical, science-based, and personalized aesthetic care. We believe in an evolving beauty – one that is supported by medical intelligence, technological precision, and a deep understanding of our patients,' says Dr. Laflamme. 'We are deeply grateful to our patients for their continued trust. It is an honour we carry with pride and responsibility.' Guided by a culture of excellence, Clinique Laflamme stands as a leader in modern aesthetic medicine. Visionary, refined, and deeply human, it remains the destination of choice for those seeking personalized care, elegant results, and a safe, cutting-edge approach to beauty and well-being. To learn more about Clinique Laflamme, CLICK HERE or visit About Consumer Choice Award: Consumer Choice Award has been recognizing and promoting business excellence in North America since 1987. Its rigorous selection process ensures that only the most outstanding service providers in each category earn this prestigious recognition. Visit to learn more. Contact Information: Sumi Saleh Communications Manager ssaleh@ SOURCE: Consumer Choice Award View the original press release on ACCESS Newswire
Hamilton Spectator
10-05-2025
- Health
- Hamilton Spectator
Quebec coroner calls for tougher controls over diphenhydramine sales after 2023 death
MONTREAL - A Quebec coroner is recommending that diphenhydramine — an antihistamine and sedative sometimes used to sleep better — should be better managed in pharmacies after the overdose death of an 18-year-old man south of Montreal in December 2023. The young man, whose identity is not revealed in the report made public, died of acute diphenhydramine poisoning at his home in St-Mathias-sur-Richelieu. On the morning of Dec. 11, 2023, the man was found by his mother in his bed, unconscious and laying on his back. Toxicological analysis found the man had a lethal level of diphenhydramine in his blood. The drug is the sedating ingredient in some over-the-counter antihistamines including the brand Benadryl, among others. The coroner found the circumstances surrounding the death raise questions about the uncontrolled availability of a potentially lethal over-the-counter substance. He noted there is consensus about the risks of poisoning among scientific bodies, but it's not stored behind the counter. 'I cannot understand why the sale of diphenhydramine … is not better controlled,' coroner Vincent Denault wrote. 'I can't understand why diphenhydramine is available over the counter, especially since Gravol, which also contains diphenhydramine, isn't available.' In a report dated from late April but released this week, the coroner wrote the man's death is attributed to the acute toxicity of diphenhydramine, a central nervous system depressant which if consumed in sufficient quantities causes fatal respiratory depression and irregular heartbeat, which can lead to fatal cardiac arrhythmias. The coroner noted there were previously used empty jars and blister packs of diphenhydramine tablets in the man's bedroom. 'Was he taking them to sleep better? Could he have taken pills in the same way, but in larger quantities, during the night of December 10-11, 2023?' the coroner asked. Denault noted it wasn't the first time deaths have occurred due to the drug. The coroner has already weighed in on three previous Quebec investigations. There was an uptick around in 2020 after the so-called Benadryl TikTok challenge on social media invited users to consume large quantities of medication tablets containing diphenhydramine. 'The deaths of children have put a face to this dangerous trend,' Denault wrote. 'The scientific literature confirms that diphenhydramine is consumed in high doses for its euphoric and hallucinogenic effects, and that people have used it to commit suicide.' Denault's recommendation was for the provincial office of professions to take steps to amend regulations involving the sale of medicinal products, to classify diphenhydramine intended for oral administration in a section that requires more management by pharmacists. That management would include creating a file, noting the sale and carrying out a pharmacological study of the file. Denault also asked the coroner's office to share the report with the Collège des médecins du Québec — the province's College of Physicians — and the Ordre des pharmaciens du Québec, the body that oversees pharmacists in the province. Jean-François Desgagné, president of the pharmacists' order, said this week the order would review the coroner's recommendation to reclassify the drug to assess the appropriateness of moving it behind the pharmacist's counter. This report by The Canadian Press was first published May 10, 2025.
Yahoo
10-05-2025
- Health
- Yahoo
Quebec coroner calls for tougher controls over diphenhydramine sales after 2023 death
MONTREAL — A Quebec coroner is recommending that diphenhydramine — an antihistamine and sedative sometimes used to sleep better — should be better managed in pharmacies after the overdose death of an 18-year-old man south of Montreal in December 2023. The young man, whose identity is not revealed in the report made public, died of acute diphenhydramine poisoning at his home in St-Mathias-sur-Richelieu. On the morning of Dec. 11, 2023, the man was found by his mother in his bed, unconscious and laying on his back. Toxicological analysis found the man had a lethal level of diphenhydramine in his blood. The drug is the sedating ingredient in some over-the-counter antihistamines including the brand Benadryl, among others. The coroner found the circumstances surrounding the death raise questions about the uncontrolled availability of a potentially lethal over-the-counter substance. He noted there is consensus about the risks of poisoning among scientific bodies, but it's not stored behind the counter. "I cannot understand why the sale of diphenhydramine … is not better controlled," coroner Vincent Denault wrote. "I can't understand why diphenhydramine is available over the counter, especially since Gravol, which also contains diphenhydramine, isn't available." In a report dated from late April but released this week, the coroner wrote the man's death is attributed to the acute toxicity of diphenhydramine, a central nervous system depressant which if consumed in sufficient quantities causes fatal respiratory depression and irregular heartbeat, which can lead to fatal cardiac arrhythmias. The coroner noted there were previously used empty jars and blister packs of diphenhydramine tablets in the man's bedroom. "Was he taking them to sleep better? Could he have taken pills in the same way, but in larger quantities, during the night of December 10-11, 2023?" the coroner asked. Denault noted it wasn't the first time deaths have occurred due to the drug. The coroner has already weighed in on three previous Quebec investigations. There was an uptick around in 2020 after the so-called Benadryl TikTok challenge on social media invited users to consume large quantities of medication tablets containing diphenhydramine. "The deaths of children have put a face to this dangerous trend," Denault wrote. "The scientific literature confirms that diphenhydramine is consumed in high doses for its euphoric and hallucinogenic effects, and that people have used it to commit suicide." Denault's recommendation was for the provincial office of professions to take steps to amend regulations involving the sale of medicinal products, to classify diphenhydramine intended for oral administration in a section that requires more management by pharmacists. That management would include creating a file, noting the sale and carrying out a pharmacological study of the file. Denault also asked the coroner's office to share the report with the Collège des médecins du Québec — the province's College of Physicians — and the Ordre des pharmaciens du Québec, the body that oversees pharmacists in the province. Jean-François Desgagné, president of the pharmacists' order, said this week the order would review the coroner's recommendation to reclassify the drug to assess the appropriateness of moving it behind the pharmacist's counter. This report by The Canadian Press was first published May 10, 2025. Sidhartha Banerjee, The Canadian Press Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
